Most Requested
bank banking bankruptcy banks bogus bonds business buy cost credit credit cards credit union credit unions debt economy employment farming Federal Reserve finance gold Government identity theft income IRS jobs lending loans marketing money mortgage mortgages real estate reserves resume rules sales savings skills small business speaking tax credit Taxes unemployment USA work-
Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
Home | Contact Us | News Archives | Resources
Interest Rates
- US: H15 -1.02 2012-05-24 FRB Market yield on U.S. Treasury securities at 5-year constant maturity, quoted on investment basis, inflation-indexed
- US: H15 0.15 2012-05-24 FRB Federal funds effective rate
- US: H15 0.13 2012-05-24 FRB 30-Day AA Nonfinancial Commercial Paper Interest Rate
- US: H15 0.73 2012-05-24 FRB Rate paid by fixed-rate payer on an interest rate swap with maturity of three year.
- US: H15 0.15 2012-05-24 FRB 60-Day AA Nonfinancial Commercial Paper Interest Rate
Trade (FTC)
- FTC Approves Modified Final Order Settling Charges that Fresenius Medical Care's Acquisition of Liberty Dialysis Holdings Was Anticompetitive in Market for Outpatient Dialysis ClinicsFollowing a public comment period, the Federal Trade Commission has approved a modified final order settling charges that Fresenius Medical Care AG and Co. KGaA's acquisition of Liberty Dialysis Holdings, Inc. would have been anticompetitive in numerous local markets for outpatient dialysis clinics around the country. […]
- FTC Approves Modified Final Order Settling Charges that Fresenius Medical Care's Acquisition of Liberty Dialysis Holdings Was Anticompetitive in Market for Outpatient Dialysis Clinics
Commerce News
- Last Call for the Low Power Television and Translator Digital Upgrade ProgramWilliam Cooperman, Director, Broadcast Division, Office of Information and Telecommunications Applications, NTIA May 25, 2012 The deadline for analog low-power television stations and translator stations to apply for a federal grant to cover digital upgrade costs is fast approaching. The last day that NTIA can accept grant applications under the Digital Upgr […]
- Last Call for the Low Power Television and Translator Digital Upgrade Program
Small Business News
- Letter dated 05/22/2012 - Federal Communications CommissionLanding page summary: The Office of Advocacy of the U.S. Small Business Administration (Advocacy) respectfully submits these comments to the Federal Communications Commission (FCC) in response to the above-referenced notice of proposed rulemaking regarding mobile device interoperability in the lower 700MHz bands. Printer Friendle Version, Fact Sheet Summari […]
- Letter dated 05/22/2012 - Federal Communications Commission
Monetary Policy
Cost Estimates
- H.R. 3857, Public Transit Security and Local Law Enforcement Support ActAs ordered reported by the House Committee on Homeland Security on May 9, 2012 H.R. 3857 would authorize appropriations for the Department of Homeland Security (DHS) to make grants to state and local governments to support security improvements to public transportation systems. CBO estimates that implementing the bill would cost $702 million over the 2012-20 […]
- S. 3240, Agriculture Reform, Food, and Jobs Act of 2012As introduced in the United States Senate on May 24, 2012 This legislation would amend and extend a number of major programs administered by the U.S. Department of Agriculture (USDA), including those addressing farm income support, food and nutrition, land conservation, trade promotion, rural development, research, forestry, energy, horticulture, and crop in […]
- H.R. 4482, a bill to amend title 38, United States Code, to make permanent home loan guaranty programs for veterans regarding adjustable rate mortgages and hybrid adjustable rate mortgagesAs ordered reported by the House Committee on Veterans’ Affairs on April 27, 2012 H.R. 4482 would make permanent the authority of the Department of Veterans Affairs (VA) to guarantee adjustable-rate mortgages and hybrid adjustable-rate mortgages (that is, mortgages with a rate that is fixed for an initial period and adjustable thereafter). Subsidy costs of t […]
- H.R. 3857, Public Transit Security and Local Law Enforcement Support Act
Banking
- Office of the Comptroller of the Currency Hosts Workshop in NebraskaThe Office of the Comptroller of the Currency will host a workshop for directors of nationally chartered community banks and federal savings associations in Omaha, Nebraska, at the Embassy Suites Omaha, July 23-25, 2012. […]
- Office of the Comptroller of the Currency Hosts Workshop in Nebraska
Urgent: Compounded Prescription Recall
Home Safety Recalls, Market Withdrawals, & Safety Alerts
Section Contents Menu
Recalls, Market Withdrawals, & Safety Alerts
PHOTO – Consumer Alert – Undeclared Sulfites In Dried Dates
PHOTO – Eating Right Soy Protein Burgers Allergy Alert And Voluntary Recall Due to Undeclared Milk
PHOTO – Pacific Oyster Company Issues Allergy Alert On Undeclared Sulfites In Nate’s Spiced Prawns
PHOTO – Rhythm Superfoods Announces Allergy Alert and Voluntary Recall of Kool Ranch Kale Chips
PHOTO – Wells Enterprises Issues Allergy Alert and Voluntary Recall due to Undeclared Wheat in some Blue Bunny Personals Ice Cream
PHOTO – Krasdale Foods Inc. Issues Allergy Alert On Undeclared Almonds In Krasdale Crispy Honey Oats and Flakes
PHOTO – Mars Food US Recalls Two Date Codes of UNCLE BEN’S Whole Grain White Rice Garden Vegetable Due to Undeclared Milk
PHOTO – Rite Aid Voluntarily Recalls 12 oz. Tins of Rich Fields Butter Cookies
Archive for Recalls, Market Withdrawals & Safety Alerts
Enforcement Reports
Industry Guidance
Major Product Recalls
- Recall — Firm Press Release
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.
Urgent: Compounded Prescription Recall
Contact
Consumer:
352-690-6773
Media:
352-622-2913
FOR IMMEDIATE RELEASE – May 25, 2012 – This is to inform you of a product recall involving:
All Sterile Human and Veterinary Prescriptions Distributed by Franck’s Pharmacy From November 21, 2011 to May 21, 2012.
This recall is being initiated after the U.S. Food and Drug Administration (“FDA”) notified us that environmental sampling of our clean room revealed the presence of microorganisms and fungal growth. In light of the FDA’s findings and the resulting possible risk of infection, we have decided that it is imperative that we recall all human and veterinary sterile preparations that have left our control. Accordingly, we are extending the recall to all sterile preparations we have provided to you since November 21, 2011.
If any of these sterile preparations remains under your control, it is essential that you do not use them and that employing appropriate practices, you destroy all such sterile preparations and all remaining portions of such sterile preparations.
This recall should be carried out to the User/Physician level. Your assistance is appreciated and necessary to prevent patient illness. Physicians should be advised to review and evaluate their patient records to determine if any adverse events may have resulted from use of the recalled products. Please report any adverse events to Franck’s Compounding Pharmacy and FDA’s MedWatch program.
FDA will expect us to be able to account for all of the sterile preparations subject to this recall. As a result, it is critically important that you read, complete, and return the enclosed response form as soon as possible.
We will update you with any relevant details as they become available to us. If you have any questions please call us at 352-690-6773, Monday through Friday from 9AM to 5 PM, EST.
This recall is being made with the knowledge of the Food and Drug Administration.